BlackRock Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3K Hold
306
﹤0.01% 3669
2016
Q3
$3K Hold
306
﹤0.01% 3677
2016
Q2
$5K Sell
306
-432
-59% -$13.5K ﹤0.01% 3669
2016
Q1
$28K Hold
738
﹤0.01% 3353
2015
Q4
$50K Sell
738
-376
-34% -$27K ﹤0.01% 3187
2015
Q3
$64K Buy
1,114
+98
+10% +$8.67K ﹤0.01% 3258
2015
Q2
$80K Buy
+1,016
New +$68.4K ﹤0.01% 3232
2015
Q1
Sell
-180
Closed -$7K 3684
2014
Q4
$7K Buy
+180
New +$7.27K ﹤0.01% 3630
2014
Q2
Sell
-838
Closed -$66K 3743
2014
Q1
$66K Buy
838
+123
+17% +$9.54K ﹤0.01% 3187
2013
Q4
$44K Buy
715
+201
+39% +$11.7K ﹤0.01% 3269
2013
Q3
$34K Buy
514
+18
+4% +$1.46K ﹤0.01% 3252
2013
Q2
$46K Buy
+496
New +$41K ﹤0.01% 3187

Other funds holding FCSC

BlackRock Advisors's FCSC Position: Q4 2016 in Review

BlackRock Advisors held its Fibrocell Science Inc. (FCSC) position steady in Q4 2016 at 306 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3669.

BlackRock Advisors first reported a position in FCSC in Q2 2013 and has held it in 12 quarters since. The position peaked at $80K in Q2 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q4 2016.

  • BlackRock Advisors held 306 shares of Fibrocell Science Inc. worth $3K as of Q4 2016.
  • BlackRock Advisors left its Fibrocell Science Inc. share count unchanged in Q4 2016.
  • Fibrocell Science Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3669 holding.
  • BlackRock Advisors first reported a position in Fibrocell Science Inc. in Q2 2013 and has held it in 12 quarters since.
  • BlackRock Advisors's Fibrocell Science Inc. position peaked at $80K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.